MASITINIB Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A member of the class of benzamides that is the carboxamide resulting from the formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]benzene-1,3-diamine. It is a highly selective oral tyrosine kinase inhibitor. (Chemical Entities of Biological Interest Ontology, CHEBI_63450)
External Link https://dgidb.org/results?searchType=drug&searchTerms=MASITINIB
Similar Terms
Downloads & Tools

Genes

14 interacting proteins for the MASITINIB drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
PDGFRA platelet-derived growth factor receptor, alpha polypeptide 0.177923
KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 0.169292
HCK HCK proto-oncogene, Src family tyrosine kinase 0.164385
PTK2B protein tyrosine kinase 2 beta 0.157536
LYN LYN proto-oncogene, Src family tyrosine kinase 0.154321
PDGFRB platelet-derived growth factor receptor, beta polypeptide 0.128165
PTK2 protein tyrosine kinase 2 0.102185
FGFR3 fibroblast growth factor receptor 3 0.101273
SRC SRC proto-oncogene, non-receptor tyrosine kinase 0.0994962
CSF1R colony stimulating factor 1 receptor 0.0406544
ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase 0.0374342
FGFR2 fibroblast growth factor receptor 2 0.0363544
FGFR1 fibroblast growth factor receptor 1 0.0264396
YES1 YES proto-oncogene 1, Src family tyrosine kinase 0.0177505